124 related articles for article (PubMed ID: 9440949)
1. [Use of photoactivation in the preparation of radiopharmaceuticals. I. Human immunoglobulin labelled with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárko I
Ceska Slov Farm; 1997 Jun; 46(3):122-7. PubMed ID: 9440949
[TBL] [Abstract][Full Text] [Related]
2. [Use of photoactivation in the preparation of radiopharmaceuticals. II. Dialysate of human leukocytes labelled with technetium (99mTc)].
Kleisner I; Komárek P; Konopková M; Komárková I
Ceska Slov Farm; 1997 Aug; 46(4):169-73. PubMed ID: 9377062
[TBL] [Abstract][Full Text] [Related]
3. [Use of photoactivation in the preparation of radiopharmaceuticals. III. Human serum albumin labelled with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 1997 Oct; 46(5):217-21. PubMed ID: 9600144
[TBL] [Abstract][Full Text] [Related]
4. The use of redox polymers in labelling procedures of proteins and peptides with 99mTc. II. Technique of preparation of kits for protein labelling by 99mTc and its effect on the stability and radiochemical purity.
Komárek P; Kleisner I; Komárková I; Konopková M
Nucl Med Rev Cent East Eur; 2000; 3(1):69-72. PubMed ID: 14600985
[TBL] [Abstract][Full Text] [Related]
5. A new technique of 99mTc-ciprofloxacin kit preparation.
Kleisner I; Komarek P; Komarkova I; Konopkova M
Nuklearmedizin; 2002 Oct; 41(5):224-9. PubMed ID: 12418309
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of radiolabelled low molecular peptides and proteins in experimental inflammation.
Komarek P; Kleisner I; Komarkova I; Konopkova M
Int J Pharm; 2005 Mar; 291(1-2):119-25. PubMed ID: 15707738
[TBL] [Abstract][Full Text] [Related]
7. [Labeling products of photochemical degradation of insulin with technetium (99mTc)].
Kleisner I; Komárek P; Klancík J; Konopková M; Komárková I
Ceska Slov Farm; 2000 Mar; 49(2):91-5. PubMed ID: 10953451
[TBL] [Abstract][Full Text] [Related]
8. [Biodistribution of low-molecular-weight proteins and technetium (99mTc) labeled peptides in an animal model of inflammation].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 2002 Sep; 51(5):252-6. PubMed ID: 12407925
[TBL] [Abstract][Full Text] [Related]
9. [Use of redox polymers for insulin labeling with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 1999 Sep; 48(5):218-20. PubMed ID: 10566241
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
11. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
[TBL] [Abstract][Full Text] [Related]
12. Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats.
Xavier Holanda CM; Cavalcanti Jales RL; Almeida Catanho MT; Holanda Leite RC; Lopes de Brito LM; Jales-Junior LH; Brandao KC; Amorim LF; de Brito Tiago GG; Gomes ML; Bernardo-Filho M
Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):761-5. PubMed ID: 12619972
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m radiopharmaceutical preparation problems: 12 years of experience.
Ponto JA
J Nucl Med Technol; 1998 Dec; 26(4):262-4. PubMed ID: 9884939
[TBL] [Abstract][Full Text] [Related]
14. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biodistribution studies of two novel radiolabeled estrone derivatives.
Enginar H; Unak P; Lambrecht FY; Biber Muftuler FZ; Medine EI
In Vivo; 2008; 22(1):93-100. PubMed ID: 18396789
[TBL] [Abstract][Full Text] [Related]
16. Biological consequences of irradiation by low doses of technetium 99m: ultrastructural studies, p53 protein expression and cytogenetic effects.
Jacquet N; Bourahla K; Guiraud-Vitaux F; Petiet A; Voisin P; Colas-Linhart N
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1139-47. PubMed ID: 10643963
[TBL] [Abstract][Full Text] [Related]
17. The effect of carrier technetium in the preparation of 99mTc-human serum albumin.
Porter WC; Dworkin HJ; Gutkowski RF
J Nucl Med; 1976 Aug; 17(8):704-6. PubMed ID: 932814
[TBL] [Abstract][Full Text] [Related]
18. Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues.
Heintz AC; Jung CM; Stehr SN; Mirtschink P; Walther M; Pietzsch J; Bergmann R; Pietzsch HJ; Spies H; Wunderlich G; Kropp J; Deussen A
Nucl Med Commun; 2007 Aug; 28(8):637-45. PubMed ID: 17625386
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m.
Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
Cancer Res; 1980 Aug; 40(8 Pt 2):3043-5. PubMed ID: 7397698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
